// App-Quantinova.ai

2813 : Treatment Patterns and Outcomes of Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Treated with Hypomethylating Agents (HMA) in the United States (US)

Researchers

Presenter

  • Timothy S. Pardee

Principal Investigators

  • Jessica Oschwald

  • Esprit Ma

  • Tao Xu

  • Melissa Montez

  • Giridharan Ramsingh

  • Wan-Jen Hong

  • Michelle Choi

  • Evelyn M. Flahavan

Medical Centers

  • Comprehensive Cancer Center of Wake Forest Baptist Health, Winston Salem, NC

  • Roche Products Ltd., Welwyn Garden City, United Kingdom

  • Genentech, Inc., South San Francisico, CA

  • F. Hoffmann-La Roche Ltd., Basel, Switzerland

  • AbbVie, Inc., North Chicago, IL

  • Roche Products Ltd., Welwyn Garden City, United Kingdom

Locations

  • United States

  • United Kingdom

  • Switzerland

Companies

  • Feng Chi Biotech Cor

  • Genentech, Inc.

  • F. Hoffmann-La Roche

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute promyelocytic leukemia

  • Acute myelocytic leukemia

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved